The prevalence of PAX5 alterations has been continually emphasized in different cohorts of B-ALL (3, 5, 7, 9, 10, 12, 15), with two B-ALL subtypes even defined by PAX5 genetic lesions and distinct gene expression profiles (GEPs) (16). Here, PAX5 is linked to precursor B-cell acute lymphoblastic leukemia.